Dynavax Technologies
DVAX
#5020
Rank
NZ$3.31 B
Marketcap
NZ$28.23
Share price
0.00%
Change (1 day)
14.03%
Change (1 year)

Dynavax Technologies (DVAX) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.51 Billion

According to Dynavax Technologies 's latest financial reports the company's total debt is NZ$0.51 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dynavax Technologies - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$0.45 B11.04%
2023-12-31NZ$0.40 B-0.03%
2022-12-31NZ$0.40 B7.84%
2021-12-31NZ$0.37 B24.81%
2020-12-31NZ$0.30 B-6.06%
2019-12-31NZ$0.32 B113.71%
2018-12-31NZ$0.15 B
2014-12-31NZ$12.2 M
2012-12-31N/A-100%
2011-12-31NZ$16.41 M7.48%
2010-12-31NZ$15.27 M-10.42%
2009-12-31NZ$17.04 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
NZ$115.09 B 22,071.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$104.36 B 20,004.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$15.21 B 2,831.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$47.80 B 9,108.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$98.17 B 18,812.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$58.71 B 11,210.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$57.25 B 10,929.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
NZ$74.14 M-85.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$30.73 B 5,820.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel